Doctor's Guide -- The US Food and Drug Administration (FDA) reminded healthcare professionals that oral nimodipine capsules should be given only by mouth or through a feeding or nasogastric tube and should never be given by intravenous (IV) administration. Nimodipine is a medication intended to be given in a critical care setting to treat neurologic complications from subarachnoid haemorrhage and is only available as a capsule.
